Skip Navigation

European Heart Journal 2002 23(4):259-260; doi:10.1053/euhj.2001.2948
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Montalescot, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montalescot, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

GPIIb/IIIa inhibition in primary stenting: ‘do it early, make it easy’

G. Montalescot

Service de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpétrière, Paris, France

References

  1. Topol EJ, Mark DB, Lincoff AM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. Lancet. 1999;354:2019–2024[CrossRef][ISI][Medline]
  2. Anderson KM, Califf RM, Stone GW. Long term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2001;37:2059–2065[Abstract/Free Full Text]
  3. Montalescot G, Barragan P, Wittemberg O. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895–1903[Abstract/Free Full Text]
  4. Collet JP, Montalescot G, Lesty C. Effects of abciximab on platelet rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation. 2001;103:2328–2331[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
E. J. Topol, F.-J. Neumann, and G. Montalescot
A preferred reperfusion strategy for acute myocardial infarction
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1886 - 1889.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Montalescot, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montalescot, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?